Activated vitronectin as a target for anticancer therapy with human antibodies

Author： Bloemendal Haiko   Boer Hetty   Koop Elianne   Dongen Alice   Goldschmeding Roel   Landman Wil   Logtenberg Ton   Gebbink Martijn   Voest Emile  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.9, 2004-09, pp. : 799-808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Endothelin Receptor: A Novel Target for Anticancer Therapy

By Pirtskhalaishvili G.   Nelson J.B.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 81-91

Adis International

Access to resources Recommend Favorite

Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 381-389

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Phosphatase 2A as a Potential Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 38-46

Bentham Science Publishers

Access to resources Recommend Favorite

The Epidermal Growth Factor receptors (EGFR): a new target for anticancer therapy

By Gainet M.   Guardiola E.   Dufresne A.   Pivot X.  

Cancer Radiotherapie, Vol. 7, Iss. 3, 2003-06 ,pp. : 195-199

Elsevier

Access to resources Recommend Favorite

Novel oncoprotein EPS8: a new target for anticancer therapy

By Li Yu-Hua   Xue Tong-Yuan   He Ying-Zhi   Du Jing-Wen  

Future Oncology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1587-1594

Future Medicine

Access to resources Recommend Favorite